Prostate cancer drug shows promise for rare salivary gland tumors
NCT ID NCT05694819
First seen Apr 14, 2026 · Last updated May 09, 2026 · Updated 4 times
Summary
This study tested a drug called darolutamide, usually used for prostate cancer, in 57 people with a rare type of salivary gland cancer that has a specific protein (androgen receptor). The goal was to see if the drug could shrink tumors or slow the cancer's growth. Some participants received darolutamide alone, while others got it combined with another hormone-blocking drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SALIVARY GLAND CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chiba University Hospital
Chiba, Chiba, 260-8677, Japan
-
Hokkaido University Hospital
Sapporo, Hokkaido, 060-8648, Japan
-
Kobe University Hospital
Kobe, Hyōgo, 650-0017, Japan
-
Nagoya University Hospital
Nagoya, Aichi-ken, 466-8560, Japan
-
National Cancer Center Hospital East
Kashiwa, Chiba, 277-8577, Japan
-
National Hospital Organization Kyushu Medical Center
Fukuoka, Fukuoka, 810-8563, Japan
-
Osaka International Cancer Institute
Osaka, Osaka, 541-8567, Japan
-
The Jikei University Hospital
Tokyo, Tokyo, 105-0003, Japan
-
Tohoku University Hospital
Sendai, Miyagi, 980-8574, Japan
-
Tokyo Medical And Dental University Hospital
Tokyo, Tokyo, 113-8519, Japan
-
Tokyo Medical University Hospital
Tokyo, Tokyo, 160-0023, Japan
-
Yokohama City University Hospital
Yokohama, Kanagawa, 236-0004, Japan
Conditions
Explore the condition pages connected to this study.